Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
[congenital adrenal hyperplasia]
Prior
studies
reveal
that
bone
mineral
density
(
BMD
)
in
congenital
adrenal
hyperplasia
(
CAH
)
is
mostly
in
the
osteopaenic
range
and
is
associated
with
lifetime
glucocorticoid
dose
.
The
forearm
,
a
measure
of
cortical
bone
density
,
has
not
been
evaluated
.
We
aimed
to
evaluate
BMD
at
various
sites
,
including
the
forearm
,
and
the
factors
associated
with
low
BMD
in
CAH
patients
.
Eighty
CAH
adults
(
47
classic
,
33
nonclassic
)
underwent
dual-energy-x-
ray
absorptiometry
and
laboratory
and
clinical
evaluation
.
BMD
Z-
scores
at
the
AP
spine
,
total
hip
,
femoral
neck
,
forearm
and
whole
body
were
examined
in
relation
to
phenotype
,
body
mass
index
,
current
glucocorticoid
dose
,
average
5
-
year
glucocorticoid
dose
,
vitamin
D
,
17
-
hydroxyprogesterone
,
androstenedione
,
testosterone
,
dehydroepiandrosterone
and
dehydroepiandrosterone
sulphate
(
DHEAS
)
.
Reduced
BMD
(
T
-
score
<
-
1
at
hip
,
spine
,
or
forearm
)
was
present
in
52
%
and
was
more
common
in
classic
than
nonclassic
patients
(
P
Â
=
Â
0
·
005
)
,
with
the
greatest
difference
observed
at
the
forearm
(
P
Â
=
Â
0
·
01
)
.
Patients
with
classic
compared
to
nonclassic
CAH
,
had
higher
17
-
hydroxyprogesterone
(
P
Â
=
Â
0
·
005
)
,
lower
DHEAS
(
P
Â
=
Â
0
·
0002
)
and
higher
non-traumatic
fracture
rate
(
P
Â
=
Â
0
·
0005
)
.
In
a
multivariate
analysis
after
adjusting
for
age
,
gender
,
height
standard
deviation
,
phenotype
and
cumulative
glucocorticoid
exposure
,
higher
DHEAS
was
independently
associated
with
higher
BMD
at
the
spine
,
radius
and
whole
body
.
Classic
CAH
patients
have
lower
BMD
than
nonclassic
patients
,
with
the
most
affected
area
being
the
forearm
.
This
first
study
of
forearm
BMD
in
CAH
patients
suggests
that
low
DHEAS
may
be
associated
with
weak
cortical
bone
independent
of
glucocorticoid
exposure
.
Diseases
Validation
Diseases presenting
"first study"
symptom
achondroplasia
acute rheumatic fever
alexander disease
aniridia
coats disease
congenital adrenal hyperplasia
cowden syndrome
dystrophic epidermolysis bullosa
erythropoietic protoporphyria
familial hypocalciuric hypercalcemia
familial mediterranean fever
heparin-induced thrombocytopenia
hirschsprung disease
krabbe disease
locked-in syndrome
oculocutaneous albinism
primary effusion lymphoma
waldenström macroglobulinemia
wiskott-aldrich syndrome
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom